5 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... Pneumonia (CAP) ... #Pneumonia #Antibiotics ... Management #Guidelines #pharmacology
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... Class Overview ... Severe cryptococcal pneumonia ... of primary and acquired ... #Pharmacology #Antibiotics
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
exacerbations, community-acquired ... pneumonia, sinusitis ... Ceftriaxone for CAP ... Used for MAC treatment ... #Pharmacology #Antibiotics
Sulfonamides - Antibiotics Class Overview

BACTRIM/SEPTRA (TMP/SMX) - inhibit sequential steps in Folate synthesis --> bacteriostatic

Spectrum: Wide
Sulfonamides - Antibiotics ... Class Overview ... choice, both for treatment ... prophylaxis), Community-acquired ... #Pharmacology #Antibiotics
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Class Overview ... (HAP/VAP, catheter-related ... empiric Pseudomonas treatment ... Polymyxin B(IV) #Pharmacology ... #Overview #AntiPseudomonal